Navigation Links
Mapi Pharma Granted United States Patent Covering Glatiramer Depot for Multiple Sclerosis
Date:5/6/2013

NESS ZIONA, Israel, May 6, 2013 /PRNewswire/ --

Mapi Pharma Ltd. (Mapi), developer of complex bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished dosage forms based on selected drug delivery systems, announced today that the company has been granted a United States patent for a long acting depot formulation of glatiramer acetate. The formulation is under development as a once-a-month treatment for Multiple Sclerosis (MS). The existing glatiramer acetate dosage form on the market today requires daily administrations (by injection).

US Patent number 8,377,885 B2 is titled Depot Systems Comprising Glatiramer or Pharmacologically Acceptable Salt Thereof. The glatiramer acetate depot formulation described therein is to be injected once-a-month under the skin or into a muscle for a prolonged release of the therapeutic agent.

"It is a bright day both for MS patients and Mapi Pharma. Today's news strengthens Mapi's patent position, supports its business plan and advances the company one step closer to bringing MS patients an improved drug to be administered once-a-month," said Mapi Pharma President & CEO Mr. Ehud Marom .

MS is a chronic, often disabling disease that attacks the central nervous system. Symptoms include numbness in the limbs, paralysis and loss of vision. Symptoms are unpredictable and differ from one person to another. The global market for MS pharmaceuticals is estimated to be approximately US $10 billion.

About Mapi-Pharma

Mapi Pharma (Mapi) is an international pharmaceutical company specializing in complex bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, high development barrier generics and novel finished dosage forms based on selected drug delivery systems. Mapi is built on strong chemical and pharmaceutical R&D capabilities, a deep understanding of the global market and of regulatory needs and its ability to foster local cooperation and enduring relationships in all of the countries in which it is present. Mapi is dedicated to providing generic and innovative intermediates & APIs as well as developing finished dosage forms - either to Mapi's internal API program, as a vertically integrated company, or generic, to other leading brands. Mapi is headquartered in Israel.  It has R&D facilities in Israel, China and Germany and is currently building an API manufacturing site in Neot Hovav, Israel's designated chemical park. The company has a strong IP position, filing more than 20 patent applications for APIs and formulations in less than three years of operation. For more information: http://www.mapi-pharma.com.

Press Contact:
Marjie Hadad
Media Liaison
Mapi Pharma
marjie@mapi-pharma.com
+972-54-536-5220


'/>"/>
SOURCE Mapi Pharma Ltd. (Mapi)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. For Pharma Companies, Launching Multiple Similar Products Can Be a "Good Problem" but Requires Smart Resourcing
2. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
3. Valeant Pharmaceuticals Provides Efinconazole Update
4. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
5. Cumberland Pharmaceuticals Reports First Quarter Financial Results
6. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
7. Webcast Alert: Isis Pharmaceuticals First Quarter 2013 Financial Results Conference Call
8. 2013 Pharmaceutical Drug Naming Trends
9. SynteractHCR Addressing Successful Ways to Approach Sponsor and CRO Collaboration at May Pharmaceutical Events in US and Europe
10. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results
11. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
(Date:5/9/2017)... , May 9, 2017 Zimmer Biomet ... in musculoskeletal healthcare, today announced it has earned a ... of 2017" list. The Company was ranked among 500 ... Large Employers and Healthcare Equipment and Services. ... based on an anonymous, independent survey of over 30,000 ...
(Date:5/8/2017)... Mich. , May 8, 2017  Diplomat Pharmacy, ... WRB Communications, Inc. ("WRB"), a health care service ... . WRB specializes in relationship management programs ... WRB will join ... Diplomat,s commercialization support services for manufacturers, biotech firms, and ...
Breaking Medicine Technology:
(Date:5/22/2017)... Matthews, NC (PRWEB) , ... May 22, 2017 ... ... of Matthews Periodontics, is now welcoming new patients with periodontal plastic surgery treatments, ... referral from a general dentist. Dr. Green provides these esthetic and functional procedures ...
(Date:5/22/2017)... ... May 22, 2017 , ... Faithfully following pop culture, people today ... jumped, toned and shaped through fitness programs. It carries on to skin nourished, pampered ... with an irresistible, radiant smile. CDA has found that just like a ...
(Date:5/21/2017)... ... May 20, 2017 , ... GetLinked® ... Services and financial systems. , Dozens of clubs using ABC Financial Services ... processed through GetLinked into their club’s accounting system , The latest implementation is ...
(Date:5/21/2017)... ... May 21, 2017 , ... For more than 20 ... a wide range of knives and swords, from functional to fantasy. United Cutlery has ... with sleek, modern designs that defy tradition. , Offering a range of weapons and ...
(Date:5/19/2017)... ... May 19, 2017 , ... DMG Productions is proud ... Innovations with Ed Begley, Jr., airing fourth quarter 2017 on FOX Business. , ... organic dietary supplement made from naturally occurring ingredients. Innovations will enlighten viewers on ...
Breaking Medicine News(10 mins):